Center Book Partners LP Mirum Pharmaceuticals, Inc. Transaction History
Center Book Partners LP
- $1.54 Billion
- Q3 2024
A detailed history of Center Book Partners LP transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Center Book Partners LP holds 11,530 shares of MIRM stock, worth $602,788. This represents 0.03% of its overall portfolio holdings.
Number of Shares
11,530
Previous 34,885
66.95%
Holding current value
$602,788
Previous $1.19 Million
62.33%
% of portfolio
0.03%
Previous 0.08%
Shares
11 transactions
Others Institutions Holding MIRM
# of Institutions
197Shares Held
54.3MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$344 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$234 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$180 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$169 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$161 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.92B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...